Most Read Articles
29 Nov 2019
Metformin Extended Release 500 mg,750 mg, and 1000 mg
29 Nov 2019
Saxagliptin 5 mg, dapagliflozin 10 mg FC tab
Roshini Claire Anthony, 4 days ago

The CA125* test could be useful at detecting ovarian cancer and various other cancers in the primary care setting, particularly for women aged >50 years, according to a study presented at the recent NCRI** Cancer Conference held in Glasgow, Scotland, UK.

4 days ago
Utilizing a clinical pharmacist specialist in a hepatitis C virus (HCV) treatment clinic may help improve drug therapy management of HCV-infected patients treated with direct-acting antivirals (DAAs), suggests a recent study.

Elevated maternal osteocalcin during early pregnancy ups risk of low birthweight

08 Oct 2018

Elevated levels of maternal osteocalcin during the first and second trimesters of pregnancy may increase the risk of having low birthweight (LBW) infants, a recent study has found.

Researchers performed a nested case-control study of 230 mothers (mean age 28.0±5.0 years) with LBW babies and 382 control pregnant mothers (mean age 28.1±4.7 years). Participants were matched for infant gender, maternal age and gestational age at blood sampling. Binary logistic regression models were used to estimate the relationship between maternal serum osteocalcin and 25-hydroxyvitamin D (25(OH)D) and LBW.

Relative to women with first trimester maternal osteocalcin 11.32 ng/mL, those with elevated levels were significantly more likely to give birth to LBW babies (20 vs 40; adjusted odds ratio [OR], 2.29; 95 percent CI, 1.11–4.72; p=0.025).

No such effect was documented for maternal 25(OH)D. There were 25 LBW infants in those with serum concentrations 64.82 nmol/L, which was not significantly different than in those with high measured levels (n=35; adjusted OR, 1.39; 0.72–2.67; p=0.325).

During the second trimester, the effect of osteocalcin remained significant (adjusted OR, 1.59; 1.03–2.45; p=0.036) while serum 25(OH)D continued to be unrelated to LBW risk (adjusted OR, 1.06; 0.69–1.62; p=0.790).

By the third trimester, the relationship between LBW risk and osteocalcin was attenuated (adjusted OR, 1.05; 0.40–2.80; p=0.919).

That osteocalcin acts as a hormone that improves glucose uptake by the foetus may explain the present findings, though further studies are required to conclusively identify the underlying mechanisms, said researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
29 Nov 2019
Metformin Extended Release 500 mg,750 mg, and 1000 mg
29 Nov 2019
Saxagliptin 5 mg, dapagliflozin 10 mg FC tab
Roshini Claire Anthony, 4 days ago

The CA125* test could be useful at detecting ovarian cancer and various other cancers in the primary care setting, particularly for women aged >50 years, according to a study presented at the recent NCRI** Cancer Conference held in Glasgow, Scotland, UK.

4 days ago
Utilizing a clinical pharmacist specialist in a hepatitis C virus (HCV) treatment clinic may help improve drug therapy management of HCV-infected patients treated with direct-acting antivirals (DAAs), suggests a recent study.